CHISLAINE MAXWELL-HY ACCT.
For the Period 11/1/11 to 11/30/I1
Type Quantity
Settle Date Selection Method Description Cost Amount
Interest Purchased
11/3 Accrued Int Paid NIELSEN FINANCE LLC/C0 7 3/4% OCT 15 2018 DID (23.25)
04115/2011 110.50 MORGAN STANLEY 8 CO. 0.00
INCORPORATED TRADE DATE 1W31/11
(ID: 654090-AY-8)
11/4 Accrued Int Pail NIELSEN FINANCE LLC/CO 7 3/4% OCT 15 2018 DTD (8.18)
04/15/2011 O 110.25 MORGAN STANLEY 8 CO. 0.00
INCORPORATED TRADE DATE 11/01/11
(ID: 654090-AY-8)
Total Interest Purchased ($31.43)
TRADE ACTIVITY
Note: S indicates Short Term Realized Gain/Loss
* Settled transaction was initiated in prior statement period and settled in current statement period
Trade Date Type Per Unit Realized
Settle Date Selection Method Description Quantity Amount Proceeds Tax Cost Gain/Loss
Settled Sales/Maturities/Redemptions
11/23 Sale CHS/COMMUNITY HEALTH SYS 87/8% JUL 15 2015 DTD (5,000.000) 101.80 5,08730 (5,433.75) (346.25) S
11/23 Pro Rata 07/25/2007 ELECTED BONDS - EXP 12/06/2011
PRORATED TENDER - HOLDERS REVEIVE $1017.50,
531.309028 IN ACCRUED INTEREST, AND S30 FOR
EVERY 1,000 PA VALIDLY TENDERED AND ACCEPTED OF
COMMUNITY HEALTH, CUSIP: 12543DAF7. TENDER
PRORATED AT A RATE OF 0.3978807155
(ID: 12599134Z-1)
J.P.Morgan Page 19 of 20
Confidential Treatment Requested by JPMorgan JPM-SDNY-00050232
Chase
CONFIDENTIAL SDNY_GM_00319430
EFTA01522665